Clinical Trials

EndocrineGenitourinaryNET

111 enrolled

Clear-cell metastatic renal cell carcinoma, Carcinoid Tumor, Carcinoma, Renal Cell, Neuroendocrine Tumors

NCT06263088 2026-05-22

EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.

200 enrolled

Anus Neoplasms, Appendiceal Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms, Neuroendocrine Tumors

NCT06959641 2026-05-22

XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer

33 enrolled

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

NCT04759911 2026-05-20

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT07376837 2026-05-19

PTC-RFA

Phase NA Enrolling by invitation

Thyroid Cancer, Papillary

NCT07595666 2026-05-19

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

1,600 enrolled

CNSEndocrineHead & Neck

Amyotrophic Lateral Sclerosis, Brain Neoplasms, Dementia, Epilepsy, Head and Neck Neoplasms, Movement Disorders, Neuroblastoma, Parathyroid Neoplasms, Parkinson Disease, Pituitary Neoplasms, Lewy Body Disease

NCT06881992 2026-05-18

Tumor HI

Phase 3 Recruiting

16 enrolled

EndocrineNETSarcoma

Fibrosarcoma, Hyperinsulinism, Hypoglycemia, Insulinoma, Adenoma, Islet Cell, Liposarcoma, Neoplasms, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors

NCT06122610 2026-05-15

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

Phase 1 Recruiting

10 enrolled

Phase 3 Not yet recruiting

Neuroendocrine Tumors

NCT07591493 2026-05-15

ADJUPANET

300 enrolled

Pancreatic Neuroendocrine Tumors (pNET)

NCT02750371 2026-05-14

ISOMAB

17 enrolled

Pituitary Neoplasms

NCT04042753 2026-05-14

Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

9 enrolled

Pituitary Diseases, Pituitary Neoplasms

NCT05988918 2026-05-14

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

17 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell, Somatostatinoma, Carcinoma, Adenosquamous

NCT06735560 2026-05-13

ELEGANCE

60 enrolled

Phase NA Active not recruiting

Cirrhosis, Familial, with Pulmonary Hypertension, Carcinoma, Hepatocellular, Cholangiocarcinoma, Neuroendocrine Tumors

NCT01704586 2026-05-12

CLERAD-PROBE

340 enrolled

Differentiated Thyroid Carcinoma

NCT05918302 2026-05-12

LEVEL

Phase 3 Recruiting

170 enrolled

Thymus Neoplasms, Neuroendocrine Tumors

NCT04848337 2026-05-11

PLANE-PC

45 enrolled 8 charts

Neuroendocrine Tumors

NCT04888481 2026-05-11

68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors

600 enrolled

Phase NA Active not recruiting

Neuroendocrine Tumors

NCT05064514 2026-05-08

TRICAR

15 enrolled

Carcinoid Heart Disease, Carcinoid Tumor, Tricuspid Valve Insufficiency, Serotonin Syndrome

NCT05368090 2026-05-08

Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

60 enrolled

Cushing Syndrome, Hyperaldosteronism, Adrenocortical Adenoma

NCT06946017 2026-05-08

Effect of a Fermented Dairy Protein With Prebiotic Fiber on GI Complaints

114 enrolled

Phase NA Enrolling by invitation

Motor Activity, Multiple Endocrine Neoplasia Type 1

NCT06954909 2026-05-08

The Impact of Self-assessment on Hydration

38 enrolled

Phase 2/3 Active not recruiting

Multiple Endocrine Neoplasia Type 1

NCT01398085 2026-05-07

IoN

504 enrolled

Phase EARLY_PHASE1 Active not recruiting

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT04544098 2026-05-07

Lutathera in People With Gastroenteropancreatic (GEP), Bronchial or Unknown Primary Neuroendocrine Tumors That Have Spread to the Liver

10 enrolled

Neuroendocrine Tumors

NCT03127774 2026-05-06

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Phase NA Not yet recruiting

EndocrineGynecologic

Peritoneal Neoplasms, Adrenocortical Carcinoma

NCT06899347 2026-05-05

PRO-COMAND

392 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Thyroid Cancer, Papillary

NCT07568366 2026-05-05

AI in Endoscopic Transsphenoidal Surgery

EndocrineGynecologicLymphoidOther solid neoplasmThoracic

Pituitary Neoplasms

NCT05337735 2026-05-04

A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers

Phase 2 Suspended

140 enrolled

Mesothelioma, Malignant, Uterine Cervical Neoplasms, Hodgkin Disease, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT02088645 2026-05-01

Lumed

Phase 1 Active not recruiting

24 enrolled

EndocrineHead & NeckNET

Thyroid cancer, medullary, Carcinoma, Medullary, Neuroendocrine Tumors

NCT03465618 2026-05-01

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

Phase 1 Active not recruiting

17 enrolled

CNSEndocrine

Brain Neoplasms, Pituitary Neoplasms

NCT07561645 2026-05-01

ALPINE 2

Phase 2 Not yet recruiting

75 enrolled

Phase EARLY_PHASE1 Active not recruiting

Lung Neoplasms, Carcinoma, Neuroendocrine

NCT03541720 2026-04-29

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

13 enrolled

CNSEndocrine

Neuroblastoma, Pheochromocytoma

NCT01744249 2026-04-28

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas

Phase 2/3 Completed

256 enrolled 25 charts

Neuroendocrine Tumors

NCT06889493 2026-04-28

SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)

Phase 1 Recruiting

36 enrolled

Phase NA Not yet recruiting

Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT07545837 2026-04-27

Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors

20 enrolled

Phase NA Active not recruiting

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

NCT05858151 2026-04-23

Transforming Food System Evaluation in Mozambique

5,216 enrolled

Multiple Endocrine Neoplasia Type 1

NCT04701307 2026-04-22

Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

48 enrolled

Lung Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT07247526 2026-04-21

Effect of Foot Bath on Anxiety and Physiological Parameters

100 enrolled

Anxiety Disorders, Pituitary Neoplasms

NCT05852223 2026-04-20

NePenThe

25 enrolled

Differentiated Thyroid Cancer

NCT05927623 2026-04-20

MisterFIt

45 enrolled

Phase NA Not yet recruiting

Muscular Atrophy, Osteoporosis, Multiple Endocrine Neoplasia Type 1, Osteoporotic Fractures

NCT07536412 2026-04-17

Decision Aid Efficacy in Low Risk Thyroid Cancer

34 enrolled

Papillary Thyroid Microcarcinoma, Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT01709292 2026-04-16

Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer

24 enrolled

Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT03110978 2026-04-16

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

140 enrolled

Phase 2 Not yet recruiting

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinoma, Neuroendocrine

NCT07470489 2026-04-16

Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer

12 enrolled

Thyroid Carcinoma, Anaplastic

NCT05470595 2026-04-15

LCNEC-ALPINE

67 enrolled

Lung Neoplasms, Carcinoma, Neuroendocrine

NCT06066333 2026-04-15

Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma

12 enrolled

Adrenocortical Carcinoma

NCT06638931 2026-04-15

ANTARES

BreastCNSEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther solid neoplasmSarcomaThoracic

28 enrolled

Urachal adenocarcinoma, Urachal cancer, Fibrolamellar hepatocellular carcinoma, Secretory breast carcinoma, Carcinoma, Ovarian Epithelial, Adrenal Gland Neoplasms, Anus Neoplasms, Biliary Tract Neoplasms, Carcinosarcoma, Carcinoma, Adenoid Cystic, Fallopian Tube Neoplasms, Fibrosarcoma, Gallbladder Neoplasms, Granulosa Cell Tumor, Hemangiosarcoma, Leiomyosarcoma, Mesothelioma, Neuroblastoma, Parathyroid Neoplasms, Penile Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Thyroid Neoplasms, Trophoblastic Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Hepatoblastoma, Endodermal Sinus Tumor, Neuroectodermal Tumors, Primitive, Cholangiocarcinoma, Sertoli-Leydig Cell Tumor, Neurofibrosarcoma, Hemangioblastoma, Neuroendocrine Tumors

NCT07485569 2026-04-15

REPOTHYROID-II

Phase 1 Not yet recruiting

10 enrolled

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT06607692 2026-04-14

LUPARPED

Phase 1/2 Recruiting

25 enrolled

CNSEndocrineNETSarcoma

Adrenal Cortex Neoplasms, Adrenal Gland Neoplasms, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Recurrence, Osteosarcoma, Sarcoma, Synovial, Esthesioneuroblastoma, Olfactory, Neuroendocrine Tumors

NCT06629220 2026-04-14

Co-creation of Tools for Men With Suicidal Thoughts and/or Behavior

13 enrolled